Colony Family Offices’s Novo Nordisk NVO Stock Holding History

Colony Family Offices’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,500	Closed	-$600K	–	77
2023 Q1	$600K	Hold	7,500	–	–	0.23%	50
2022 Q4	$508K	Sell	7,500 -2,568	-26%	-$151K	0.21%	47
2022 Q3	$502K	Hold	10,068	–	–	0.22%	48
2022 Q2	$561K	Buy	+10,068	New	+$559K	0.25%	42

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Colony Family Offices's NVO Position: Q2 2023 in Review

Colony Family Offices sold out of Novo Nordisk (NVO) in Q2 2023, closing a stake of 7,500 shares — an estimated $600K sold.

Colony Family Offices first reported a position in NVO in Q2 2022 and held it in 4 quarters. The position peaked at $600K in Q1 2023. 1,197 funds tracked by Wall St. Rank hold NVO as of Q2 2023.

Colony Family Offices reported no remaining Novo Nordisk position as of Q2 2023 after selling out during the quarter.
Colony Family Offices sold 7,500 Novo Nordisk shares in Q2 2023, an estimated $600K.
Colony Family Offices first reported a position in Novo Nordisk in Q2 2022 and held it in 4 quarters.
Colony Family Offices's Novo Nordisk position peaked at $600K in Q1 2023.
1,197 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.

Based on Colony Family Offices's 13F filing for Q2 2023, filed 27 Jul 2023.